RA375

Research use only, not for human use.

RA375, an inhibitor of RPN13 (26S proteasome regulatory subunit), enhances UPR signaling, ROS production, and apoptosis.

RA375 is a RPN13 (26S proteasome regulatory subunit) inhibitor. RA375 activates UPR signaling, ROS production and apoptosis. RA375 exhibits ten-fold greater activity against cancer lines than RA190, reflecting its nitro ring substituents and the addition of a chloroacetamide warhead.

——

RA375 (10 mg/kg, ip) inhibits proteasome function and reduces ovarian tumor burden in mice.Animal Model:RA375 (10 mg/kg, ip) inhibits proteasome function and reduces ovarian tumor burden in mice.Dosage:10 mg/kg.Administration:IP for a 5 days on, 2 days off cycle for two weeks.Result:Reduced ovarian tumor burden in mice.Animal Model:Female Balb/c mice.Dosage:5, 10, 20, 40, 60, 100 mg/kg (Pharmacological Analysis).Administration:IP single dose.Result:The dose of 40 mg/kg on alternate days for two weeks produced no observable toxicities or weight loss.

——

Proteasome/Ubiquitin

Proteasome

Proteasome

——

——

2649154-57-2

588.99

C30H25ClN4O7

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (169.78 mM; Ultrasonic )

O=C(CCl)N[C@H](C(N1C/C(C(/C(C1)=C/C2=CC=C([N+]([O-])=O)C=C2)=O)=C\C3=CC=C([N+]([O-])=O)C=C3)=O)CC4=CC=CC=C4

——

(-20℃)

With Ice Pack

≥ 2 years